- Ivabradine for patients with stable coronary artery disease and left - ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial2008 | First Faculty of Medicine
- Ivabradine in patients with stable ischemic heart disease and left ventricular systolic dysfunction: the results of the BEAUTIFUL study2009 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Catecholamines Induce Left Ventricular Subclinical Systolic Dysfunction: A Speckle-Tracking Echocardiography Study2019 | First Faculty of Medicine
- Aortic stenosis with systolic dysfunction of the left ventriclePublication without faculty affiliation
- Aortic stenosis with left ventricular systolic dysfunctionPublication without faculty affiliation
- NT-proBNP and BNP values in cardiac patients with different degree of left ventricular systolic dysfunction2006 | First Faculty of Medicine, Faculty of Physical Education and Sport, Second Faculty of Medicine
- Sacubitril/valsartan in the treatment of heart failure with severe left ventricular systolic dysfunction2021 | First Faculty of Medicine
- Ivabradine in patients with stable ischemic heart disease and left ventricular systolic dysfunction: the results of the BEAUTIFUL study2009 | Central Library of Charles University
- Ivabradine in patients with stable ischemic heart disease and left ventricular systolic dysfunction: the results of the BEAUTIFUL study2009 | Faculty of Medicine in Pilsen
- B-type natriuretic peptide: powerful predictor of end-stage chronic heart failure in individuals with systolic dysfunction of the systemic right ventricle2016 | Central Library of Charles University
- Adrenal pheochromocytoma as a rare cause of reversible left ventricular systolic dysfunction and malignant arrhythmias: a case series2022 | Central Library of Charles University, First Faculty of Medicine
- Severe Left Ventricular Systolic Dysfunction is Independently Associated with High On-Clopidogrel Platelet Reactivity2014 | Third Faculty of Medicine
- Improved clinical status persisting for several months while on sacubitrilvalsartan in a patient with systolic dysfunction of rather unclear etiology2017 | First Faculty of Medicine
- Hospital and mid-term results of surgery for mitral valve regurgitation in patients with severe left ventricular systolic dysfunction2008 | Second Faculty of Medicine
- Cardiovascular manifestations in paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS)2022 | Second Faculty of Medicine
- Utilization protein biochips in diagnostics ischemic damage infarction2014 | Faculty of Medicine in Hradec Králové
- Tako-tsubo cardiomyopathy with both ventricles involvement2011 | First Faculty of Medicine
- Eplerenone reduces mortality 30 days after randomization following acute myocardial infarction in patients with left ventricular systolic dysfunction and heart failure2005 | First Faculty of Medicine
- Eplerenone reduces mortality 30 days after randomization following acute myocardial infarction in patients with left ventricular systolic dysfunction and heart failure2005 | Faculty of Physical Education and Sport
- Long-term clinical outcomes and left ventricular reverse remodeling in recently diagnosed unexplained delated cardiomyopathy2024 | First Faculty of Medicine, Faculty of Physical Education and Sport
- Trajectories and determinants of left ventricular ejection fraction after the first myocardial infarction in the current era of primary coronary interventions2022 | Central Library of Charles University, First Faculty of Medicine
- The BEAUTIFUL study: Randomized trial of ivabradine in patients with stable coronary artery disease and left ventricular systolic dysfunction - baseline characteristics of the study population2008 | First Faculty of Medicine
- Rationale and design of a randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary artery disease and left ventriculat systolic dysfunction2006 | Faculty of Physical Education and Sport
- Echocardiographic evaluation of the right ventricular function2014 | First Faculty of Medicine
- Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial2008 | First Faculty of Medicine
- Mortality and morbidity reduction with candesartan in patients with chronic heart failure and left ventricular systolic dysfunction. Results of the CHARM low-left ventricular ejection fraction trials2004 | First Faculty of Medicine
- BEAUTIFUL Study. The effect of ivabradine on risk of cardiovascular events in patients with CAD and systolic dysfunction of left ventricle. Does slowing of heart rate improve prognosis of patients with CAD?2006 | First Faculty of Medicine
- Mortality and morbidity reduction with candesartan in patients with chronic heart failure and left ventricular systolic dysfunction. Results of the CHARM low-left ventricular ejection fraction trials2004 | Faculty of Physical Education and Sport
- Diabetic cardiomyopathy: pathophysiological mechanisms of structural and functional changes2016 | Faculty of Medicine in Pilsen
- Computational modeling of ventricular-ventricular interactions suggest a role in clinical conditions involving heart failure2023 | First Faculty of Medicine